Latest filing published 09 Sept 2026 for Bio-Rad Laboratories, INC..
Jonathan P. DiVincenzo has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Labcorp Holdings Inc., Bio-Rad Laboratories, Inc. and Revvity, Inc. In total, 18 filings cover trades dated from 9 February 2016 to 5 September 2026.
No open-market purchase appears, only 1 sale worth €100k. Besides market trades, the filings include 9 share grants and 8 option exercises.
On 9 September 2026 came the latest disclosure, an option exercise in Bio-Rad Laboratories, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations